At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,448 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CEE PMSS (Central Eastern European Post-Marketing Surveillance Study) First Presentation of Mirapexin in Parkinson Patients
In Brief
An observational study for Parkinson Disease. Completed, enrolled 2,448 participants across 311 sites in 9 countries.
Detailed Summary
In this study information is gathered about the treatment of Parkinson patients who present themselves in a neurological practice for the first time
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesCroatia, Czechia, Estonia, Hungary, Romania, Russia, Serbia, Slovakia, Slovenia
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2006
Primary CompletionSep 2007
First PostedDec 2008
TodayJul 2026
First PostedDec 4, 2008
Enrollment StartFeb 1, 2006
Primary CompletionSep 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 17.6 years ago